Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × dehydroftorafur × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Rectal Neoplasms 3 Colonic Neoplasms 3 Pancreatic Adenocarcinoma 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Tongue Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Salivary Gland Neoplasms 1 Pancreatic Intraductal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Lymphoid Interstitial Pneumonia 1 Klatskin Tumor 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Bile Duct Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 21 atezolizumab 12 Gemcitabine 12 Nivolumab 10 Cisplatin 10 Docetaxel 8 Carboplatin 8 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 epacadostat 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 enfortumab vedotin 2 cabozantinib 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡